Cite
HARVARD Citation
Baker, D. et al. (n.d.). Response to Becher and Strohner comment regarding Baker DL et al. Evaluation of two commercial omalizumab/free IgE immunoassays: implications of use during therapy. CMRO 2014;30:913-22. Current medical research and opinion. pp. 1927-1929. [Online].